This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Technology offers benefits like enhanced education but poses challenges such as reduced human connection and ethical concerns. Effective psychiatric leadership requires balancing generational and technological dynamics to foster collaboration and innovation.
Trontinemab showed significant amyloid plaque reduction in Alzheimer's, validating Brainshuttle technology and prompting a phase 3 study. MindMed initiated a phase 3 study of MM120 for major depressive disorder, with results expected in the second half of 2026. Results are expected in 2026.
Specialized Credentials Matter: Trauma-informed care certification LGBTQ+ cultural competency training Eatingdisorder specialist credentials Substance abuse counseling certifications Many therapists list their areas of expertise on their professional profiles.
The technology was officially launched at an Open Day in the Department of Psychiatry on June 6. The technology will be used by researchers working across the Departments of Psychiatry, Nuffield Department of Clinical Neurosciences and Experimental Psychology at Oxford.
Individuals with mental disorders have significantly higher rates of other comorbid medical disorders that are under investigation as potential treatment targets for GLP-1 RAs, including binge eatingdisorder, polycystic ovarian syndrome, and noncirrhotic nonalcoholic steatohepatitis. 8 Are GLP-1 RAs Psychiatric Drugs?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content